Anthera Pharmaceuticals Inc. (ANTH) News Nov 12, 2
Post# of 250601
Posted On: 11/21/2014 4:54:21 AM
Anthera Pharmaceuticals Inc. (ANTH) News Nov 12, 2014, 4:00 p.m.
MarketWatch News on ANTH
Stock futures edge up after retail, claims data 9:23 a.m. Dec. 12, 2013 - Victor Reklaitis
Stocks to watch Thursday: Libbey, J.M. Smucker 5:56 a.m. July 19, 2012 - MarketWatch
Anthera cut to sell by Citigroup 7:42 a.m. June 29, 2012 - Greg Morcroft
Thursday’s top gaining and declining stocks 3:54 p.m. June 28, 2012 - MarketWatch
Anthera plunges on drug study 9:36 a.m. June 28, 2012 - Val Brickates Kennedy
Stocks to watch Friday: UPS, AK Steel, AmeriGas 5:43 a.m. March 16, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:24 p.m. March 12, 2012 - Kate Gibson
Anthera plunges 50% on failed study 10:50 a.m. March 12, 2012 - Val Brickates Kennedy
U.S. stock futures fall before euro-area meeting 8:04 a.m. March 12, 2012 - Barbara Kollmeyer
Stocks to watch Monday: Coca-Cola, Michael Kors 5:45 a.m. March 12, 2012 - MarketWatch
Green Mountain slips, Anthera sinks after hours 6:47 p.m. March 9, 2012 - Carla Mozee
Anthera shares plunge 60% in after-hours trade 5:46 p.m. March 9, 2012 - Carla Mozee
Friday’s biggest gaining & declining stocks 3:36 p.m. Dec. 2, 2011 - Kate Gibson
Tuesday’s biggest gaining and declining stocks 2:08 p.m. May 17, 2011 - Greg Morcroft
Pernix leads drug stocks south 12:31 p.m. May 17, 2011 - Val Brickates Kennedy
Other News on ANTH
10-Q: ANTHERA PHARMACEUTICALS INC 4:57 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns 9:16 a.m. Nov. 7, 2014 - Seeking Alpha
Qiagen's Molecular Diagnostics, Global Market Show Strength - Analyst Blog 1:50 p.m. Sept. 26, 2014 - Zacks.com
Genomic Health Upbeat on Strong International Performance - Analyst Blog 2:00 p.m. Sept. 25, 2014 - Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape 8:30 a.m. Sept. 25, 2014 - Zacks.com
The 52-Week Low Club for Friday 2:58 p.m. Sept. 5, 2014 - 247WallSt.com
10-Q: ANTHERA PHARMACEUTICALS INC 12:06 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Anthera (ANTH) Enters Oversold Territory - Tale of the Tape 9:41 a.m. Aug. 11, 2014 - Zacks.com
Anthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape 8:31 a.m. Aug. 4, 2014 - Zacks.com
Anthera Acquires Sollpura from Eli Lilly - Analyst Blog 4:20 p.m. July 18, 2014 - Zacks.com
Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape 8:04 a.m. July 15, 2014 - Zacks.com
Anthera buys pancreatic therapy from Eli Lilly 4:31 p.m. July 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 8:30 a.m. July 14, 2014 - TheStreet.com
Fire Up The Immuno-Oncology Powerhouses: John McCamant 4:39 p.m. June 19, 2014 - Seeking Alpha
Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape 7:51 a.m. May 16, 2014 - Zacks.com
10-Q: ANTHERA PHARMACEUTICALS INC 4:25 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: ANTHERA PHARMACEUTICALS INC 4:22 p.m. March 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
Anthera Pharmaceuticals: Recent Developments, Both Good And Bad 12:20 p.m. Oct. 31, 2013 - Seeking Alpha
A Promising Future For Anthera's Blisibimod 4:58 p.m. Sept. 27, 2013 - Seeking Alpha
BioLineRx Files for BL-7010 Study Initiation - Analyst Blog 4:25 p.m. Sept. 25, 2013 - Zacks.com
Press Releases on ANTH
Anthera and Patheon Sign Manufacturing Agreement for Liprotamase Phase III Registration Trial 11:00 a.m. Nov. 20, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 4:05 p.m. Nov. 14, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod 3:00 p.m. Oct. 1, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 4:40 p.m. July 28, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company 3:42 p.m. July 14, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors 4:00 p.m. June 23, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors 2:30 p.m. June 13, 2014 - PR Newswire - PRF
Top Gainers Technical Data -- Research on Zix, Textura, Recon Technology, and Anthera Pharma 9:46 a.m. May 16, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update 7:30 a.m. May 13, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Announces Personnel Changes 3:30 p.m. March 31, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update 5:01 p.m. March 12, 2014 - PR Newswire - PRF
Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company 4:05 p.m. Feb. 10, 2014 - Marketwire
Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences 4:42 p.m. Jan. 30, 2014 - PR Newswire - PRF
FLG Partners Announces Chris Lowe as a New Partner 1:09 p.m. Jan. 28, 2014 - Marketwire
Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 5:00 p.m. Nov. 27, 2013 - PR Newswire
Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update 3:30 p.m. Oct. 29, 2013 - PR Newswire
Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting 7:30 a.m. Sept. 25, 2013 - PR Newswire
Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results 4:14 p.m. July 30, 2013 - PR Newswire
Technical Briefing: Accuray, Antares Pharma, Chelsea Therapeutics, and Anthera Pharma 10:15 a.m. July 26, 2013 - PR Newswire
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock 4:00 p.m. July 12, 2013 - PR Newswire
MarketWatch News on ANTH
Stock futures edge up after retail, claims data 9:23 a.m. Dec. 12, 2013 - Victor Reklaitis
Stocks to watch Thursday: Libbey, J.M. Smucker 5:56 a.m. July 19, 2012 - MarketWatch
Anthera cut to sell by Citigroup 7:42 a.m. June 29, 2012 - Greg Morcroft
Thursday’s top gaining and declining stocks 3:54 p.m. June 28, 2012 - MarketWatch
Anthera plunges on drug study 9:36 a.m. June 28, 2012 - Val Brickates Kennedy
Stocks to watch Friday: UPS, AK Steel, AmeriGas 5:43 a.m. March 16, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:24 p.m. March 12, 2012 - Kate Gibson
Anthera plunges 50% on failed study 10:50 a.m. March 12, 2012 - Val Brickates Kennedy
U.S. stock futures fall before euro-area meeting 8:04 a.m. March 12, 2012 - Barbara Kollmeyer
Stocks to watch Monday: Coca-Cola, Michael Kors 5:45 a.m. March 12, 2012 - MarketWatch
Green Mountain slips, Anthera sinks after hours 6:47 p.m. March 9, 2012 - Carla Mozee
Anthera shares plunge 60% in after-hours trade 5:46 p.m. March 9, 2012 - Carla Mozee
Friday’s biggest gaining & declining stocks 3:36 p.m. Dec. 2, 2011 - Kate Gibson
Tuesday’s biggest gaining and declining stocks 2:08 p.m. May 17, 2011 - Greg Morcroft
Pernix leads drug stocks south 12:31 p.m. May 17, 2011 - Val Brickates Kennedy
Other News on ANTH
10-Q: ANTHERA PHARMACEUTICALS INC 4:57 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Biotech Watchlist Update: Small-Cap Biotechs Struggle, But Investors Remain Enchanted By Big Pharma's Returns 9:16 a.m. Nov. 7, 2014 - Seeking Alpha
Qiagen's Molecular Diagnostics, Global Market Show Strength - Analyst Blog 1:50 p.m. Sept. 26, 2014 - Zacks.com
Genomic Health Upbeat on Strong International Performance - Analyst Blog 2:00 p.m. Sept. 25, 2014 - Zacks.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape 8:30 a.m. Sept. 25, 2014 - Zacks.com
The 52-Week Low Club for Friday 2:58 p.m. Sept. 5, 2014 - 247WallSt.com
10-Q: ANTHERA PHARMACEUTICALS INC 12:06 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Anthera (ANTH) Enters Oversold Territory - Tale of the Tape 9:41 a.m. Aug. 11, 2014 - Zacks.com
Anthera Pharmaceuticals (ANTH) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape 8:31 a.m. Aug. 4, 2014 - Zacks.com
Anthera Acquires Sollpura from Eli Lilly - Analyst Blog 4:20 p.m. July 18, 2014 - Zacks.com
Exelixis (EXEL) Soars: Stock Adds 23% in Session - Tale of the Tape 8:04 a.m. July 15, 2014 - Zacks.com
Anthera buys pancreatic therapy from Eli Lilly 4:31 p.m. July 14, 2014 - Seeking Alpha
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 8:30 a.m. July 14, 2014 - TheStreet.com
Fire Up The Immuno-Oncology Powerhouses: John McCamant 4:39 p.m. June 19, 2014 - Seeking Alpha
Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 10.3% - Tale of the Tape 7:51 a.m. May 16, 2014 - Zacks.com
10-Q: ANTHERA PHARMACEUTICALS INC 4:25 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: ANTHERA PHARMACEUTICALS INC 4:22 p.m. March 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
Anthera Pharmaceuticals: Recent Developments, Both Good And Bad 12:20 p.m. Oct. 31, 2013 - Seeking Alpha
A Promising Future For Anthera's Blisibimod 4:58 p.m. Sept. 27, 2013 - Seeking Alpha
BioLineRx Files for BL-7010 Study Initiation - Analyst Blog 4:25 p.m. Sept. 25, 2013 - Zacks.com
Press Releases on ANTH
Anthera and Patheon Sign Manufacturing Agreement for Liprotamase Phase III Registration Trial 11:00 a.m. Nov. 20, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update 4:05 p.m. Nov. 14, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Announces Update on Strategic Partnership Discussions for Blisibimod 3:00 p.m. Oct. 1, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 4:40 p.m. July 28, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company 3:42 p.m. July 14, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors 4:00 p.m. June 23, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors 2:30 p.m. June 13, 2014 - PR Newswire - PRF
Top Gainers Technical Data -- Research on Zix, Textura, Recon Technology, and Anthera Pharma 9:46 a.m. May 16, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results and Operational Update 7:30 a.m. May 13, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Announces Personnel Changes 3:30 p.m. March 31, 2014 - PR Newswire - PRF
Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results and Operational Update 5:01 p.m. March 12, 2014 - PR Newswire - PRF
Hansen Medical Announces Appointment of Chris Lowe as Interim CEO; Bruce Barclay to Depart the Company 4:05 p.m. Feb. 10, 2014 - Marketwire
Anthera Pharmaceuticals to Present at Leerink Swann, Cowen & Co., and BIO CEO Healthcare Conferences 4:42 p.m. Jan. 30, 2014 - PR Newswire - PRF
FLG Partners Announces Chris Lowe as a New Partner 1:09 p.m. Jan. 28, 2014 - Marketwire
Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 5:00 p.m. Nov. 27, 2013 - PR Newswire
Anthera Pharmaceuticals Reports 2013 Third Quarter Financial Results, Clinical and Regulatory Update 3:30 p.m. Oct. 29, 2013 - PR Newswire
Anthera Pharmaceuticals Announces Emerging Data from Phase 2 Open-Label Extension Study to be Presented at the ACR/ARHP 2013 Annual Scientific Meeting 7:30 a.m. Sept. 25, 2013 - PR Newswire
Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results 4:14 p.m. July 30, 2013 - PR Newswire
Technical Briefing: Accuray, Antares Pharma, Chelsea Therapeutics, and Anthera Pharma 10:15 a.m. July 26, 2013 - PR Newswire
Anthera Pharmaceuticals Announces 1-for-8 Reverse Split of Stock 4:00 p.m. July 12, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼